Trial Profile
Clinical trial to evaluate the safety of Temsirolimus combined with Vincristine and Irinotecan in children with recurrent/refractory solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2022
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Irinotecan; Vincristine
- Indications Brain cancer; Ewing's sarcoma; Hepatoblastoma; Neuroblastoma; Osteosarcoma; Retinoblastoma; Rhabdomyosarcoma; Sarcoma; Solid tumours; Wilms' tumour
- Focus Adverse reactions
- 11 Oct 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan.
- 12 May 2015 New trial record